CYduct Diagnostics, Inc. (CYDX)

OTCMKTS · Delayed Price · Currency is USD
0.745
0.00 (0.00%)
At close: Mar 4, 2026
272.30%
Market Cap 3.90M
Revenue (ttm) 344.78K
Net Income (ttm) 136.51K
Shares Out 5.24M
EPS (ttm) n/a
PE Ratio 28.59
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 900
Average Volume 7,218
Open 1.010
Previous Close n/a
Day's Range 0.745 - 1.010
52-Week Range 0.200 - 2.900
Beta -1.10
RSI 45.30
Earnings Date n/a

About CYduct Diagnostics

CYduct Diagnostics, Inc., a healthcare company, develops, produces, and markets medical devices for the assessment, identification, diagnosis and treatment of breast cancer. The company offers HALO system, a noninvasive device that utilizes proprietary technology to obtain breast fluid; and MammoView, a fiberoptic technology with the ability to view and collect cells and other abnormalities. It also provides women and clinicians with technology that will lead the Intraductal approach to breast cancer and improvement in breast healthcare. The co... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1986
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol CYDX
Full Company Profile

Financial Performance

In 2011, CYduct Diagnostics's revenue was $328,612, a decrease of -23.48% compared to the previous year's $429,473. Losses were -$503,787, -57.75% less than in 2010.

Financial Statements

News

There is no news available yet.